Marksans PharmaMARKSANS 
$3.20-1.87%24h
-1.87%24h
Global rank6329
Market cap$1.33B
Change 7d1.30%
YTD Performance64.95%
SP500 benchmarkOutperform
P/E0.50
P/S6.02
Revenue$220.50M
Earnings$31.63M
Dividend yield-
Main Sector
Healthcare
Category
Marksans Pharma (MARKSANS) Total Liabilities
MARKSANS Total Liabilities in 2022: $50.70M
According to Marksans Pharma latest financial reports the total liabilities of MARKSANS is $50.70M, an increase of 1.96% to 2022. At the end of 2022 company had $49.73M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Marksans Pharma is responsible for during its operational activities.
Marksans Pharma (MARKSANS) Total Liabilities History from 2023 to 2022
-
Value:-
MARKSANS Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $50.70M | 1.96% |
| 2022 | $49.73M | 28.96% |
| 2021 | $38.56M | 27.58% |
| 2020 | $30.23M | 15.49% |
| 2019 | $26.17M | - |
View the Top Total Liabilies Stocks
